Upender Velaparthi,David B. Frennesson,Mark G. Saulnier,Joel F. Austin,Audris Huang,James Aaron Balog,Dolatrai M. Vyas
申请号：
US13814384
公开号：
US08673922B2
申请日:
2011.07.14
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Disclosed are azaindazole compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein W is CR4 or N and R1, R2, R3, and R4 are defined herein. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 associated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.
